- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
Search Results
240 results for dgse
3 Healthcare Stocks for Retirement Investors
Medical costs keep on rising. For investors in retirement, a dose of healthcare stocks could be the key to dealing with those costs.
FDA Win Sends Celsion Corporation (CLSN) Shares Higher
Celsion (CLSN) shares were up Thursday as the company received FDA clearance on its plans to start a Phase I/II clinical trial of OVATION II.
Pfizer’s Covid-19 Vaccine Delay Isn’t Welcome News for Shareholders
The UK’s chief medical officers want to delay second doses of the Pfizer/BioNTech vaccine. Is this much ado about nothing for PFE stock?
Real Goods Solar, Inc. (RGSE) Stock Skyrockets on Dow Deal
Real Goods Solar (RGSE) stock was skyrocketing today following news of a deal with Dow (DWDP) concerning solar shingles.
Why Southwest Airlines Co, AT&T Inc., and General Motors Company Are Today’s 3 Worst Stocks
A healthy dose of skepticism, as well as some poor financial results and lowered forecasts, drove these three names lower on Thursday.
Pfizer to Sell Vaccine to Poor Countries for Fraction of Price
Pfizer has agreed to sell its vaccine Prevnar 13 to poor countries for a fraction of the price. The vaccine will be sold for $3.50…
Ignore the Naysayers and Invest in Novavax Stock
NVAX stock boasts one of the strongest long-term cases in the biotech industry despite being criticized by the press.
2 Emerging Market Dividend ETFs for Adventurous Investors
Valuations for emerging markets are tantalizingly inexpensive and the darkest dividend clouds may have already passed. For the adventurous, here are some ideas to consider…
Trade of the Day: Arrowhead Research (ARWR)
ARWR has a potentially revolutionary product here by most standards.
Why Cara Therapeutics Inc (CARA) Stock Is Plunging Today
Cara Therapeutics (CARA) stock was hit hard on Friday following poor results in its Phase 2b trial of osteoarthritis oral drug CR845.
Gilead Sciences Is a Strong Buy Despite What Its Detractors Might Say
Gilead Sciences is donating 1.5 million doses of remdesivir, which has many analysts bullish on GILD stock now.
Inovio Stock Is Still a Strong Coronavirus-Related Bet to Make
Inovio is speeding toward a vaccine for the coronavirus and has plans to make 1 million doses by the end of the year to boost…
Novavax Has Growth Potential Both Now and After the Pandemic
Novavax has a Covid-19 vaccine already in production. With a world that still needs billions of doses, NVAX stock is positioned for growth.
Rigel Pharmaceuticals, Inc. (RIGL) Up Nearly 50% on Study Results, Price Target Increase
Rigel Pharmaceuticals, Inc. (RIGL) is flying high today after two doses of good news, as the stock strayed into overbought territory.
Why Amazon.com, Inc., Ford Motor Company and Helmerich & Payne, Inc. Are Today’s 3 Worst Stocks
Falling oil prices, disappointing earnings and a healthy dose of Wall Street skepticism sent these three big names lower Friday.
Carnival Stock Sees A Strong Rally But Is It Worth Your Time?
CCL stock sees a strong rally after a double dose of vaccine news but investors should still proceed with caution on this investment.
AK Steel: The Charts Are Turning Around for AKS Stock
Tuesday’s earnings-driven rally in AKS stock appears to have given the charts of AK Steel a dose of momentum with a chance to last.
Why Is Vanda Pharmaceuticals (VNDA) Stock Up 33% Today?
Vanda Pharmaceuticals stock is rising higher on Wednesday as investors in VNDA celebrate FDA approval of its bipolar treatment.
4 – 10 of 240 results